Share: Facebook Twitter LinkedIn
Activity Provided By:

American Academy of CME

Best of ACTHIV: Initial Treatment for a Person with HIV Infection

Access Activity

Overview / Abstract:

This session was voted by attendees and the ACTHIV conference planning committee as one of the “Best of ACTHIV”. The 13th Annual American Conference for the Treatment of HIV (ACTHIV) was held April 11-13, 2019 in Miami, FL.

At the completion of this educational activity, participants will:
1. Individualize initial antiretroviral therapy for a person with HIV infection

2. Evaluate new options for treating HIV

Expiration

Sep 15, 2020

Discipline(s)

Nurse Practitioner , Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™; 0.5 ANCC Contact Hours (0.4 pharmacotherapeutic contact hours); 0.5 AAPA Category 1 CME credits

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

Dr. Gandhi is Associate Professor of Medicine at Harvard Medical School, and the Director of HIV Clinical Services and Education at Massachusetts General Hospital (MGH). Dr. Gandhi is site leader of the MGH AIDS Clinical Research Site in the Harvard/Miriam AIDS Clinical Trials Unit (ACTU) and vice-chair of the AIDS Clinical Trials Group HIV-1 Reservoirs and Eradication Transformative Science Group. He is also the Director of the Harvard University Center for AIDS Research Clinical Core. Dr. Gandhi is the editor of Partners ID Images, an educational infectious diseases website, and organizer of the HIV Online Provider Education (HOPE) program, an internet-based educational conference series for physicians caring for HIV patients in resource-limited settings. His research interests include clinical trials of immune-based therapies for HIV, HIV reservoirs, and HIV/viral hepatitis coinfections.

Activity Specialities / Related Topics

Case Management, HIV / AIDS, Infectious Disease, Internal Medicine, Primary Care

Sponsors / Supporters / Grant Providers

Supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., and ViiV HealthCare

Keywords / Search Terms

American Academy of CME HIV infection antiretroviral therapy Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map